logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Oxandrolone CAS 53-39-4

Oxandrolone CAS 53-39-4

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 53-39-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
53-39-4
Appearance::
White Crystalline Powder
Molecular Formula::
C19H30O3
Molecular Weight::
306.44000
EINECS NO::
200-172-9
MDL NO::
MFCD00198944
CAS NO::
53-39-4
Appearance::
White Crystalline Powder
Molecular Formula::
C19H30O3
Molecular Weight::
306.44000
EINECS NO::
200-172-9
MDL NO::
MFCD00198944
Oxandrolone CAS 53-39-4

Product Description:

Product Name: Oxandrolone CAS NO: 53-39-4

 

 

Synonyms:

Lonavar;

Protivar;

Vasorome;

 

 

Chemical & Physical Properties:

Appearance: White crystalline powder

Assay :≥99.0%

Density: 1.105g/cm3

Boiling Point: 444.4℃at 760mmHg

Melting Point: 235-238℃

Flash Point: 179.1℃

Refractive Index: 1.526

Storage Condition: Controlled Substance, -20℃ Freezer

 

 

Safety Information:

RTECS: RN6800700

HS Code: 2937290022

Symbol: GHS07, GHS08

Signal Word: Danger

Hazard Declaration: H312 + H332; H360

Caution Statement: P201; P280; P308 + P313

 

 

A synthetic, anabolic s-teroid. Used to promote muscle growth and combat involuntary weight loss. It has also been used to treat cases of osteoporosis. The use of oxandrolone, an analog of testos-terone possessing only 5% of testos-terone's virilizing androgenic effects, enhances anabolism of muscle protein by improving the efficiency of protein synthesis in severely burned children. Oxandrolone administration decreases loss of body weight and improves healing of the donor site wound. In a large clinical trial by our group, 0.1 mg/kg oxandrolone administered twice daily reduced length of the acute hospitalization, sustained LBM, and improved liver protein synthesis. Severely burned pediatric patients receiving oxandrolone for 1 year experienced improved growth, decreased cardiac work, and improved muscle strength. Oxandrolone treatment also improved lung function at rest and during exercise in this patient population. These improvements were maintained for up to 4 years after treatment had ended. The benefits of oxandrolone administration after burn injury were further enhanced when the treatment period was increased from 1 to 2 years.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.